This chapter describes the methodology adopted in a project aimed at structural and functional characterization of proteins that potentially play an important role in mammalian macrophages. The methodology that underpins this project is applicable to both small research groups and larger structural genomics consortia. Gene products with putative roles in macrophage function are identified using gene expression information obtained via DNA microarray technology. Specific targets for structural and functional characterization are then selected based on a set of criteria aimed at maximizing insight into function. The target proteins are cloned using a modification of Gateway® cloning technology, expressed with hexa-histidine tags in E. coli, and purified to homogeneity using a combination of affinity and size exclusion chromatography. Purified proteins are finally subjected to crystallization trials and/or NMR-based screening to identify candidates for structure determination. Where crystallography and NMR approaches are unsuccessful, chemical cross-linking is employed to obtain structural information. This resulting structural information is used to guide cell biology experiments to further investigate the cellular and molecular function of the targets in macrophage biology. Jointly, the data sheds light on the molecular and cellular functions of macrophage proteins.
Introduction
Structural genomics initiatives aim to provide a comprehensive view of the protein structure universe by determining structures of representative proteins from every protein family (1) . Achieving such a goal requires large, coordinated research teams and substantial funding (2) . However, the parallel processing and high-throughput approaches adopted by structural genomics initiatives can also be applied to projects of smaller scale, and promise faster and more cost-effective results. Furthermore, a smaller team can identify a niche in the world-wide structural genomics initiative through careful protein target selection. We have applied these ideas to a project aimed at the structural characterization of proteins that play important roles in macrophage function.
Macrophages are cells representing the first line of defence against pathogens and play crucial roles in both innate and acquired immunity. They comprise 15-20% of cells in most organs, and are particularly abundant at the routes of pathogen entry such as lung, skin, gut and genitourinary tract (3) . Macrophages detect pathogens by receptors that recognise generic non-mammalian structures including cell wall components (e.g. lipopolysaccharide, LPS; peptidoglycans; lipotechoic acids) and microbial DNA (e.g. unmethylated CpG motifs) (4) . Upon recognition, the macrophage engulfs and destroys the foreign organism, while at the same time activating a spectrum of genes, creating a hostile extracellular environment in the host. Additional cells are recruited to the site of invasion and an appropriate acquired immune response is primed dependent on the 4 class of pathogen. However, some pathogens have been able to evade these defences, and in some cases, such as Mycobacterium tuberculosis, take advantage of the macrophage as a portal of infection and replicate or survive within this cell type. This can lead to life-threatening conditions such as disseminated intravascular coagulation, hypotension, and pathological fever (5) . In chronic local infections, or in response to inflammation caused by non-infectious agents that activate macrophages but cannot be cleared, macrophage products cause local tissue destruction and the wasting disease known as cachexia (6) .
A detailed knowledge of the regulation of macrophage function will form the basis for the development of two classes of therapeutics. On one hand, it may be desirable to amplify the toxic function of macrophages to destroy microorganisms or tumor cells more effectively. Alternatively, selective suppression of components of the macrophage activation response offers approaches to treatment of acute conditions such as septicemia and toxic shock, and chronic conditions such as arthritis, atherosclerosis and obstructive lung disease (7).
To understand better the process of macrophage activation, we have undertaken a program to structurally and functionally characterize novel proteins involved in macrophage activation (8) . Here we present the methodology of our pipeline (Fig. 1), focusing on target selection, cloning, expression, purification, and structural characterization of proteins involved in macrophage activation. The pipeline is applicable to both small research groups within academia and larger consortia. The primer sequences are generated automatically using an in-house Perl script that takes target nucleotide sequences as an input, generating primer sequences that start at the termini, contain additional bases to reach an annealing temperature of 55 °C, and end in a cytosine or guanine.
Cloning
The target genes are amplified by PCR using a macrophage cDNA pool or cDNAs from FANTOM2 clonesets (13) . The PCR products are purified from primers and other buffer components using the Montage 96-well PCR purification kit (Millipore) set up on the Biomek 2000 workstation.
The PCR products are cloned into expression vectors using a modification of the Gateway recombinatorial cloning methodology that allows expression of the recombinant proteins with a short hexa-histidine tag (14, 15) . The purified PCR products are cloned into the Gateway entry vector pDONR-221 (Invitrogen) using a two-step PCR followed by a recombinatorial LR reaction (15) . A gene-specific primer containing a linker of 12 nucleotides is used in the first PCR step, and a BP-reaction "universal adapter primer" (15) containing hexa-histidine tag is employed in the second 
Expression and Purification
As reported by the worldwide SG Centers TargetDB Statistics Report (Oct 2, 2006), only about 25% (30% for prokaryotes and viruses, 15% for eukaryotes) of clones can be successfully expressed and purified. The main hurdle is protein solubility in the non-native host. We use conventional expression and purification procedures for the soluble targets, while protein refolding (Section 2.4) is used as a salvage pathway for the insoluble proteins. An estimation of the protein expression and solubility in E. coli is achieved rapidly in 1-ml cultures followed by purification in 96-well format. The analysis with an automated electrophoresis instrument (Caliper 96 Bioanalyzer) enables prompt quantification of the yields and the subsequent choice of targets suitable for large-scale purification or refolding. The expression and purification protocol is outlined below followed by the protein refolding procedure in Section 2.4. Targets with accurate size are ranked according to the yield and selected for large-scale expression and purification.
Large-scale Expression and Purification
Target proteins selected from the small-scale expression trials are produced in large mM Hepes (pH 7.4), 150 mM NaCl is concentrated using Amicon Ultra Centrifugal
Filter Devices (Millipore) typically to ~20 mg/ml for protein characterization and crystallization.
Protein Refolding
Insoluble protein expression may be the biggest bottleneck limiting structure genomics initiatives (17) . While 20-60% of proteins expressed in E. coli result in insoluble inclusion bodies (18) (19) (20) , many of these proteins may be amenable to refolding. We have developed a matrix-assisted refolding approach, in which correctly folded proteins are distinguished from misfolded proteins by their elution from affinity resin (21) . Proteins that are subjected to refolding while bound to metal affinity resin are often resistant to elution by imidazole. We hypothesized that misfolded proteins 
Protein Characterization
SDS-PAGE, size exclusion chromatography, mass spectrometry and circular dichroism (CD) spectroscopy are used to characterize the proteins after purification. there are fewer limitations on buffer components and data collection is faster (22) . CD 11 spectra yield information on protein secondary structure, and are therefore particularly useful for identifying proteins with large proportions of unstructured regions that are unlikely to yield useful high-resolution structural information.
NMR Spectroscopy
For a subset of proteins with a molecular weight less than 20 kDa, NMR spectroscopy is also used to assess their suitability for structure MHz spectrometer equipped with a z-shielded gradient triple resonance probe, and analyzed using NMRPipe/NMRDraw (23) . NMR spectral quality and feasibility of three-dimensional structure determination is assessed based on spectral dispersion, line widths, and number of resolved peaks observed compared to the number expected from the amino acid sequence.
Crystallography

Protein Concentration Optimization
The optimal protein concentration for crystallization screens is determined by 
Crystallization
The 
Structure determination
The X-ray diffraction quality of protein crystals is assessed using an in-house
Rigaku FR-E rotating anode generator (Rigaku/MSC, Texas, USA) with a RaxisIV++ image plate detector. Crystals of native protein are flash-cooled in a nitrogen gas stream 13 at ~100 K after soaking in a suitable cryoprotectant.
When diffraction quality crystals are obtained and a suitable molecular replacement model is not available, the protein is expressed in minimal media in the presence of SeMet to produce SeMet-labeled protein crystals for use in MAD phasing (27) at a synchrotron. Standard crystallographic packages such as HKL2000 (28), CrystalClear (Rigaku), SOLVE (29) , Arp/Warp (30), the CCP4 package (31) and Coot (32) are used to process the data, obtain phase information, build the model, refine and visualize the structures.
Cross-linking
Chemical cross-linking is employed to obtain structural information on proteins for which structure determination by x-ray diffraction and NMR are not successful. The (Fig. 2) .
Functions Revealed
Latexin is the only known mammalian carboxypeptidase inhibitor. We have shown that latexin is expressed constitutively at high basal levels in mouse macrophages and can be further upregulated by stimulation of the cells with growth factor or proinflammatory stimuli (33) . The crystal structure of latexin (Fig. 2) unexpectedly revealed structural similarities with the cysteine protease inhibitor cystatin (33) .
Together, the data suggest a role for latexin in the regulation of proteolysis during inflammation.
Acyl-CoA thioesterases (ACOTs) are a family of enzymes that are conserved through evolution from bacteria to mammals. These proteins catalyze the hydrolysis of acyl-CoA moieties to the respective fatty acid constituents and coenzyme A (34).
Long-chain acyl-CoAs are intermediates in lipid metabolism and regulators of cellular processes including ion transport, vesicle trafficking, protein phosphorylation and gene expression (34) (35) (36) . Mouse ACOT7 contains two thioesterase domains in tandem. We have determined the crystal structures of each domain separately, and modeled the 16 full-length protein using distance constraints based on chemical cross-linking (Fig. 2) .
The structure explains the requirement of the two domains for enzymatic activity and the structural basis for long-chain acyl-CoA specificity. 
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